Author:
Lam Catherine G.,Furman Wayne L.,Wang Chong,Spunt Sheri L.,Wu Jianrong,Ivy Percy,Santana Victor M.,McGregor Lisa M.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Oncology,Hematology,Pediatrics, Perinatology and Child Health
Reference38 articles.
1. . Ifosfamidecarboplatinetoposide (ICE) for recurrent malignant solid tumors of childhood: a Pediatric Oncology Group Phase III study.;Kung;J Pediatr Hematol Oncol,1995
2. . Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors. Response and toxicity.;van Hoff;Cancer,1995
3. The use of ifosfamide, carboplatin, and etoposide in children with solid tumors.;Cairo;Semin Oncol,1995
4. . Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.;Brock;J Clin Oncol,2012
5. . Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.;Skinner;Eur J Cancer,2009
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献